1-15 of 15
Keywords: Interferon
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal: Dermatology
Dermatology (2015) 231 (2): 158–163.
Published Online: 17 June 2015
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Plasmacytoid dendritic cells Lupus erythematosus Lichen planopilaris and frontal fibrosing alopecia Interferon MxA BDCA-2...
Journal Articles
Journal Articles
Journal: Dermatology
Dermatologica (1984) 169 (1): 47–48.
Published Online: 13 October 2009
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Interferon Persistent viral warts Dermatológica 169: 47-48 (1984) ©...
Journal Articles
Journal: Dermatology
Dermatologica (1987) 174 (4): 199–205.
Published Online: 13 October 2009
...A. Bourlond; D. Dubois; R. de Sélys Immunotherapy with interferon and transfer factor has been tried in 2 cases of Kaposi’s sarcoma of the Mediterranean type, without visceral involvement. Clinical benefits appeared almost worthless and biological data hardly improved. On the contrary, side effects...
Journal Articles
Journal: Dermatology
Dermatologica (1985) 171 (4): 220–225.
Published Online: 13 October 2009
... during the first 2 months of treatment, but thereafter returned to starting values. Interferon reactivity (IFN-α, IFN-γ) was essentially unaltered by the treatment. It is concluded that moderate oral retinoid doses cause a mild, transient stimulation of this natural immune surveillance system in man...
Journal Articles
Journal: Dermatology
Dermatologica (1988) 177 (3): 175–179.
Published Online: 09 October 2009
... of the right kidney leading to subsequent surgical procedures including the establishment of an ilealbladder and exstirpation of the right ureter and nephrectomy of the right kidney. Treatment with recombinant interferon alpha-2A 1.8 mU for 5 days a week resulted in steady regression of all tumor masses. After...
Journal Articles
Journal: Dermatology
Dermatologica (1989) 179 (1): 34–37.
Published Online: 09 October 2009
...J.F. Nicolas; J.C. Balblanc; A. Frappaz; B. Chouvet; M. Delcombel; J. Thivolet In this study we treated 6 patients with epidermotropic cutaneous T cell lymphoma (CTCL) with intermediate doses of recombinant alpha 2a interferon (18–100 × 10 6 IU/week) for 2–6 months. One patient experienced complete...
Journal Articles
Journal Articles
Journal: Dermatology
Dermatology (1992) 184 (1): 40–44.
Published Online: 08 October 2009
...J. Shupack; M. Stiller; I. Davis; C. Kenny; L. Jondreau The recent in vivo appearance of acyclovir-resistant strains of herpes simplex virus stresses the need for new therapeutic agents to combat this common virus. Topical interferon preparations may help fill this void. In the present study...
Journal Articles
Journal Articles
Journal Articles
Journal: Dermatology
Dermatology (2004) 208 (4): 345–348.
Published Online: 16 June 2004
.... We report here a case with disseminated skin and gastrointestinal venous malformations and findings of disseminated intravascular coagulation that was treated with interferon β. The disseminated intravascular coagulation manifestations were cleared with the treatment. The regression...
Journal Articles
Journal Articles
Journal: Dermatology
Dermatology (2000) 200 (4): 331–333.
Published Online: 06 July 2000
..., verrucous carcinoma of the nose, renal cell and transitional cell carcinomas of the left kidney, adenoma of the colon and a positive family history of colon carcinoma. He was treated with interferon (IFN-α2a) s.c. 3 × 10 6 U three times a week along with 50 mg isotretinoin daily as well as topical...
Journal Articles
Journal: Dermatology
Dermatology (2000) 200 (2): 160–166.
Published Online: 14 April 2000
... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Melanoma Staging system Treatment Interferon Immunotherapy Report...